SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-24-050057
Filing Date
2024-04-29
Accepted
2024-04-29 17:19:04
Documents
17
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A apto-20231231.htm   iXBRL 10-K/A 703978
2 EX-31.1 apto-ex31_1.htm EX-31.1 12758
3 EX-31.2 apto-ex31_2.htm EX-31.2 12834
4 EX-32.1 apto-ex32_1.htm EX-32.1 5984
5 EX-32.2 apto-ex32_2.htm EX-32.2 6076
6 GRAPHIC img238830913_0.jpg GRAPHIC 25469
7 GRAPHIC img238830913_1.jpg GRAPHIC 24175
  Complete submission text file 0000950170-24-050057.txt   1126734

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT apto-20231231.xsd EX-101.SCH 42249
20 EXTRACTED XBRL INSTANCE DOCUMENT apto-20231231_htm.xml XML 10434
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-32001 | Film No.: 24892834
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)